Sperm-specific phospholipase C zeta (PLCζ) is widely considered to be the physiological stimulus that evokes intracellular calcium (Ca 2+ ) oscillations that are essential for the initiation of egg activation during mammalian fertilization. A recent genetic study reported a male infertility case that was directly associated with a point mutation in PLC C2 domain, where an isoleucine residue had been substituted with a phenylalanine (I489F). Here in, we have analysed the effect of this mutation on the in vivo Ca 2+ oscillation-inducing activity and the in vitro biochemical properties of human PLC. Microinjection of cRNA or recombinant protein corresponding to PLCζ I489F mutant at physiological concentrations completely failed to cause Ca 2+ oscillations and trigger development. However, this infertile phenotype could be effectively rescued by microinjection of relatively high (non-physiological) amounts of recombinant mutant PLC I489F protein, leading to Ca 2+ oscillations and egg activation. Our in vitro biochemical analysis suggested that PLC I489F mutant displayed similar enzymatic properties but dramatically reduced binding to PI(3)P and PI(5)P-containing liposomes compared to wild-type PLC. Our findings highlight the importance of PLC at fertilization and the vital role of the C2 domain in PLC function, possibly due to its novel binding characteristics.
INTRODUCTION
In mammalian oocytes (eggs), the fertilizing sperm evokes a series of pre-programmed biochemical and morphological events collectively known as 'egg activation'. It is now well established in all mammalian species studied, that the earliest step of egg activation involves marked increases in the levels of the egg cytosolic calcium concentration [Ca 2+ ], which are both necessary and sufficient for activation and early embryonic development [1] [2] [3] . Despite recent controversies, a gamete-specific phospholipase C (PLC) isoform, PLC is widely considered as the physiological stimulus that induces the characteristic series of large cytoplasmic Ca 2+ transients, known as Ca 2+ oscillations, within the fertilizing oocyte [3] [4] [5] [6] [7] [8] .
Sperm PLC is delivered from the fertilizing sperm into the egg cytoplasm, catalyses the hydrolysis of its membrane-bound phospholipid substrate, phosphatidylinositol 4,5bisphosphate (PIP2), triggering the cytoplasmic Ca 2+ oscillations through the inositol 1,4,5trisphosphate (InsP3) signaling pathway [3, 4, 9] . PLC appears to be the smallest currently known mammalian PLC isozyme, with the most basic domain organization amongst all PLC isoforms. PLC consists of four EF hand domains at the N-terminus, the characteristic X and Y catalytic domains in the centre, followed by a C-terminal C2 domain [4, 9] . Thus, PLC possesses a similar domain organization to PLC1 with the remarkable exception that it lacks an N-terminal pleckstrin homology (PH) domain [9] . The notable lack of a PH domain, makes it unclear how this sperm-specific PLC isoform directly interacts and targets biological membranes. A recent report, suggested that the N-terminal lobe of the EF-hand domain of PLC together with its positively charged XY-linker, has an essential role to provide a tether that facilitates proper PIP2 substrate access and binding in the PLC active site [10] . However, the exact mechanism that PLC targets the PIP2-containing membrane is still unknown.
Evidence for the clinical importance of PLC has been provided by studies that have directly linked reduced expression levels and abnormal forms of PLC with male infertility [5, [11] [12] [13] [14] [15] . A very recent genetic study, using whole-exome sequencing analysis identified a homozygous missense mutation in the PLC gene of two infertile brothers from Tunisia, presenting oocyte activation failure [8] . This mutation was located in the C2 domain of PLC, where an isoleucine at position I489 had been replaced with a phenylalanine (I489F), (Fig. 1A ) [8] . Interestingly, this is the first male infertility-linked PLC point mutation to be reported within the C2 domain of PLC, a domain which although is well known to be essential for PLC function, its exact role still remains unclear. It was shown that I489F mutation results in some loss of Ca 2+ oscillation-inducing activity of PLC in eggs, but the degree of loss of activity was not quantified and the poor ability of the PLC mutant to trigger Ca 2+ oscillations was not extensively characterized [8] .
In the present study we introduced the infertility-linked PLC I489F mutation into human PLC sequence and we analysed the effect of this mutation on both the in vivo Ca 2+ oscillation-inducing activity and the in vitro biochemical/enzymatic properties of human PLC. For comparison, cRNA encoding luciferase-tagged versions of wild-type and PLC I489F mutant or bacterially-expressed recombinant proteins were microinjected into unfertilised mouse and bovine eggs. Circular Dichroism (CD) spectroscopy was used to investigate whether the I489F mutation interferes with the proper folding of the C2 domain. The enzymatic and biochemical properties of PLC WT and PLC I489F mutant were analyzed using an in vitro [ 3 H]PIP2 hydrolysis and liposome binding assays.
MATERIALS AND METHODS

Plasmid construction
Human PLCζ-luciferase in pCR3 vector [5] was subjected to site-directed mutagenesis (QuikChange II; Stratagene) to generate the PLCζ I489F mutant. PLCζ WT and PLCζ I489F mutant were amplified by PCR from the corresponding pCR3 plasmid using Phusion polymerase (Finnzymes) and the appropriate primers to incorporate a 5'-SalI site and a 3'-NotI site and were cloned into a modified pET expression vector (pETMM41). The primers used for the minutes centrifugation at 20,000 g at 4°C, to remove the insoluble proteins, the soluble MBPtagged fusion proteins were purified by affinity chromatography using amylose resin column following standard procedures (New England Biolabs). Eluted proteins were then dialyzed and concentrated using centrifugal concentrators (Sartorius; 10,000 molecular weight cut-off).
SDS-PAGE and Western blot
Recombinant MBP fusion protein were separated by SDS-PAGE and immunoblot analysis was performed as described previously [10] . Proteins were probed with a monoclonal penta-His antibody (1:5,000 dilution). 
Preparation and handling of mouse oocytes
Preparation and handling of bovine oocytes
Ovaries were collected after slaughter from the local abattoir and transported to the laboratory at 24 o C in PBS (Sigma P4417) within 1 hour. Cumulus oocyte complexes were collected by slashing the surface of the ovary with a scalpel in Medium 199 -Hepes buffered and the solution was passed through a 100-micron mesh filter in order to retain the cumulus oocyte complexes (COC). COC were placed in maturation media for 22h [16] . After completion of maturation COC were vortexed for 3-4 min in hyaluronidase in order to isolate the mature eggs, which were immediately washed and transferred in M2 media until use.
Protein microinjection and measurements of intracellular Ca 2+
Eggs were in incubated in M2 media containing Cal-520 AM (5 μM) for 30 minutes at 37 o C before the experiment. Eggs were held in M2 for microinjection [17] . Recombinant PLCζ WT and PLCζ I489F mutant fusion proteins were diluted in injection buffer (120 mM KCl, 20 mM Hepes, pH 7.4) prior to introduction into oocytes using a high pressure injection method. Alexa Fluor 594 (1 mM) was used as a loading control to ensure the equal protein volume injection. Eggs were imaged in HKSOM media using a Nikon TE2000 inverted epifluorescence microscope connected to a cooled intesified CCD camera (Photek,UK) and fluorescence was recorded by photon counting software (Photek,UK). In cases where luciferase expression was measured the fluorescence (to quantify Ca 2+ changes) was recorded alternately using a 10 second switching cycle [18] . The fluorescence signal was normalised to relative fluorescence by plotting absolute fluorescence divided by basal level fluorescence (F/F0). All egg experiments were conducted within a three (3) week period.
cRNA microinjection and measurements of intracellular Ca 2+ and luciferase expression
Eggs were held in M2 for microinjection. cRNA was diluted in injection buffer (120 mM KCl, 20 mM Hepes, pH 7.4) and in the case of cRNA also mixed with 1 mM Oregon Green BAPTA dextran OGBD (Life Technologies) prior to introduction into oocytes using a high pressure injection method [17] . Bolus injection calculated the amount of injection solution microinjected that was approximately 3-5% of oocyte volume. Eggs were imaged in HKSOM media containing 100 μM luciferin using a Nikon TE2000 inverted epifluorescence microscope connected to a cooled intensified CCD camera (Photek,UK) and both luminescence and fluorescence were recorded by photon counting software (Photek, UK). Luminescence (quantifying luciferase expression) and fluorescence (quantifying Ca 2+ changes) were recorded alternately using a 10 second switching cycle [18] with these 2 signals being plotted individually for each oocyte over the same time scale. The fluorescence signal was normalised to relative fluorescence by plotting absolute fluorescence divided by basal level fluorescence (F/F0) and luminescence was plotted as a running average over 5 minutes. All egg experiments were conducted within a 3-month period.
CD spectroscopy
CD spectra of MBP, MBP-C2 WT and MBP-C2 I489F were recorded on an Aviv model 215 instrument (Aviv Biomedical Inc., Lakewood, NJ) using a 0.1-cm quartz cell at 4 °C.
Proteins were dissolved in 100 mM NaF, 20 mM KH2PO4/NaOH, pH 7.0, at a concentration of ~ 0.15 mg/ml. Concentrations were determined based on the absorbance at 280 nm assuming extinction coefficients derived from the amino acid composition [19] . Secondary structure content was analysed using the CDsstr algorithm [20] as implemented on DichroWeb [21] using the SMP180 reference spectra [22] .
Thermal stability was monitored at 221nm in 0.5 °C intervals from 4 °C to 70 °C (MBP) or up to a maximum temperature when protein aggregation was observed as indicated by a sharp increase of the dynode voltage with settings resulting in an average heating rate of ~ 30 °C/h. Apparent melting temperatures Tm and van't Hoff's enthalpies ΔHvH were estimated from non-linear curve fitting assuming a 2-state folded-to-unfolded transition as described [23] with the ellipticity of the unfolded state set as that observed for MBP.
Molecular modelling
Structural models of MBP, MBP-C2 WT and MBP-C2 I489F were generated using SWISS-MODEL with the corresponding parts of the PDB coordinates 3mq9 (residues 5 to 366) and 1djg (rat PLCδ1, residues 496 to 624) as templates [24] .
PIP2 hydrolysis assays
The PIP2 hydrolytic activity of recombinant MBP-tagged PLC proteins was determined as described previously [5, 10, 25] [10, 26] .
Km and EC50 values of Ca 2+ dependence for PIP2 hydrolysis for the MBP-tagged PLC recombinant proteins were determined by non-linear regression analysis (GraphPad Prism 5).
Liposome preparation and binding assays.
Unilamellar liposomes were prepared as previously described [10, 26] . For the proteinliposome binding experiments, liposomes (100 µg) were incubated with 1 µg of each MBPtagged recombinant protein for 30 min at room temperature and centrifuged for 5 hours at 4
°C. Supernatants and pellets were analysed either by SDS-PAGE and Coomassie Brilliant Blue staining or by the [ 3 H]PIP2 hydrolysis assay, as previously described [10] .
RESULTS
Microinjection of cRNA encoding PLC I489F mutant completely failed to trigger Ca 2+ oscillations when expressed at physiological concentrations in mouse eggs
To investigate the impact of I489F mutation on the in vivo Ca 2+ oscillation-inducing activity of human PLC, we used site-directed mutagenesis to generate the PLCζ I489F mutant.
To enable direct comparative analysis with PLC WT and to verify that this construct was faithfully expressed as protein in cRNA-microinjected unfertilized mouse eggs, we produced this mutant as a luciferase-fusion construct, as previously described [10, 26, 27] . Table 1 ). In contrast, microinjection of cRNA corresponding to PLCζ I489F -LUC mutant failed to cause any Ca 2+ oscillations at equivalent protein expression levels (0.06 c.p.s.), ( Fig. 1B right panel, Table 1 ).
Interestingly, expression of PLCζ I489F -LUC mutant at significantly higher levels (0.74 c.p.s.)
led to low frequency Ca 2+ oscillations (2.3 spikes in the first hour of oscillating), (Fig. 1C , Table 1 ), suggesting that overexpression of PLCζ I489F -LUC, which leads to overload of this mutant within the egg cytoplasm, can induce Ca 2+ release from intracellular stores.
Microinjection of MBP-PLCζ I489F protein is less effective at triggering Ca 2+ oscillations in mouse eggs
PLCζ WT and PLCζ I489F mutant were then subcloned into the pETMM41 expression vector to allow prokaryotic expression of these constructs, as 6xHis-MBP-fusion recombinant proteins. We have previously demonstrated that NusA is a powerful fusion partner for PLC, significantly enhancing the bacterial expression, protein solubility, as well as the purified recombinant protein stability over time [5, 10] . In this study, we demonstrate for first time that in addition to NusA, MBP tag is an extremely effective protein tag for PLC. Our comparative experiments with NusA tag showed that MBP is an effective protein fusion partner for PLC preserving its stability over time (data not shown).
Optimal protein production for these MBP-fusion PLC constructs required induction of protein expression with 0.1 mM IPTG for 18 h at 16 0 C. Following bacterial expression in E. coli and isolation by amylose resin affinity chromatography, the purified recombinant proteins were analysed by SDS-PAGE and immunoblot analysis using an anti-His (penta-His) monoclonal antibody ( Fig. 2A ). The dominant protein band with mobility corresponding to the predicted molecular mass for MBP-PLC WT and MBP-PLCζ I489F mutant was observed for both recombinant fusion proteins (~118 kDa). These major bands were also confirmed by immunoblot analysis by the penta-His antibody ( Fig. 2A right panel) . Some additional, fainter, low molecular weight bands could be observed, which were also detected by the penta-His antibody and were probably the result of protease degradation occurring during the various stages of protein expression and purification. Microinjection of MBP-PLC WT into mouse eggs at a concentration of 0.0375 mg/ml revealed that it possesses a potent ability to trigger cytoplasmic Ca 2+ oscillations ( Fig. 2B; upper panel) , matching that observed after microinjection of native sperm extracts [28] . Microinjection of the MBP protein alone was unable to induce Ca 2+ release. Interestingly, microinjection of MBP-PLCζ I489F mutant protein at equivalent levels that MBP-PLCζ WT triggered physiological Ca 2+ oscillations (0.0375 mg/ml), was either unable to induce any Ca 2+ oscillations (13/23 eggs) or could only trigger very low frequency Ca 2+ oscillations (10/23 eggs), (Fig. 2B; lower panel) .
To investigate whether it was possible to rescue the low frequency Ca 2+ oscillations, MBP-PLCζ I489F recombinant protein was microinjected at higher levels. We found that a 2-fold increase in the amount of MBP-PLCζ I489F mutant (0.075 mg/ml) microinjected into mouse eggs was able to rescue the defective Ca 2+ oscillation-inducing phenotype and trigger egg activation, as indicated by cleavage of the 2-cell stage (Fig. 3) . These findings agree with our previous observations, suggesting that overload of PLCζ I489F mutant within the mouse egg cytoplasm, can induce Ca 2+ oscillations.
MBP-PLC WT protein is more potent in triggering Ca 2+ oscillations in bovine eggs than
MBP-PLCζ I489F
To examine whether our previous observations regarding the ability of PLCζ I489F mutant to trigger Ca 2+ oscillations in mouse eggs are consistent in eggs of a different species, we compared the abilities of MBP-PLCζ WT and MBP-PLCζ I489F recombinant proteins to induce Ca 2+ oscillations in bovine eggs. The optimal concentration for MBP-PLCζ WT to induce a physiological pattern of Ca 2+ oscillations in bovine eggs was 0.15 mg/ml. In contrast, microinjection of MBP-PLCζ I489F mutant protein at this concentration was able to trigger very low frequency Ca 2+ oscillations in all microinjected eggs (Fig. 4 ).
I489F does not alter the folding and the thermal stability of PLC C2 domain
To investigate whether I489F mutation within the C2 domain of PLC interferes with the proper folding of this domain, we analysed the MBP-tagged wild type and mutant C2 domains (C2 WT and C2 I489F ) by CD spectroscopy. Attempts to produce an untagged or 6xHistag version of the C2 domain of PLC WT using the bacterial expression system proved unsuccessful, as the protein appeared to be completely insoluble, accumulating into inclusion bodies. Thus, C2 WT and C2 I489F (Fig. 5A) Assuming a two-state folded-to-unfolded transition and extrapolating to the ellipticity observed for unfolded MBP, fitting of the data resulted in melting temperature Tm = 60.5 ± 0.5 0 C and van't Hoff's enthalpies of ~560 and ~250 kJ/mol for MBP and the two fusion proteins, respectively. For MBP, these values agree with those previously reported [29] .
I489F does not alter the in vitro enzymatic properties of human PLC
We then examined the impact of I489F mutation on the in vitro enzymatic properties of PLC. To determine the specific PIP2 hydrolytic enzyme activities for PLC WT and PLC I489F a micellar [ 3 H]PIP2 hydrolysis assay was used as previously described [10, 27, 30] .
The histogram of Fig. 7A and Table 2 reveal that the enzymatic activities of PLC WT and PLC I489F were almost identical (960±43 vs 953±49 nmol/min/mg), suggesting that I489F mutation has no effect on the ability of PLC to hydrolyse in vitro PIP2. In order, to investigate the effect of I489F mutation on Ca 2+ sensitivity of PLCζ enzyme activity we assessed the ability of PLC WT and PLC I489F to hydrolyse [ 3 H]PIP2 at different Ca 2+ concentrations ranging from 0.1 nM to 0.1 mM. The resulting EC50 values for PLC WT (66 nM) and PLC I489F (60 nM)
were very similar ( Fig. 7B , Table 2 ). In addition, calculation of the Michaelis-Menten constant Km, for PLC WT and PLC I489F also yielded in comparable values (81 vs 93 µM), ( Table 2) , indicating that I489F mutation has no effect on the Ca 2+ sensitivity or on the in vitro enzymatic affinity of PLC for its substrate, PIP2.
I489F dramatically reduces the binding of PLC to PI(3)P and PI(5)P
The only specific binding partners for PLC C2 domain that have been in vitro identified up to date are PI(3)P and PI(5)P [31, 32]. To examine the binding properties of PLC I489F to PIP2, PI(3)P and PI(5)P we employed two different approaches, a liposomebinding (pull-down) and a liposome-binding/enzyme assay, as previously described [10, 26] .
For these experiments, we prepared unilamellar liposomes, which were composed of PC:CHOL:PE (4:2:1) with incorporation of either 1% PIP2, 5% PI(3)P or 5% PI(5)P. For diminishing the non-specific protein binding to highly charged lipids, the liposome binding experiments were performed in the presence of a near-physiological concentration of MgCl2 (0.5mM) [26] . The MBP moiety alone served as the negative control for our experiments. As shown in Fig. 8 , MBP did not exhibit any specific liposome binding in the absence or presence of PIP2, PI(3)P and PI(5)P, whereas our positive control MBP-PLC WT displayed robust binding to liposomes containing either 1% PIP2, 5% PI(3)P or 5% PI(5)P. On the other hand, MBP-C2 WT showed significant binding only to liposomes containing either 5% PI(3)P or 5% PI(5)P. In contrast, although MBP-PLC I489F was able to bind strongly to liposomes containing 1% PIP2, its binding to liposomes containing either 5% PI(3)P or 5% PI(5)P significantly diminished (Fig. 8) . Similarly, MBP-C2 I489F was unable to bind liposomes containing 5% PI(3)P or 5% PI(5)P. These findings clearly suggest that I489F mutation clearly affects the binding of PLC C2 domain to PI(3)P and PI (5) binding, we estimated the relative binding of each PLC protein to the different phosphoinositide specific-containing liposomes [10] . As shown at histograms in Fig. 9 , the binding of PLC WT and PLC I489F to PIP2-containing liposomes was almost identical, while the binding of PLC I489F to PI(3)P-and PI(5)P-containing liposomes had been reduced by ~50% compared to PLC WT , suggesting that I489F mutation indeed dramatically reduces the binding of PLC to PI(3)P and PI(5)P.
DISCUSSION
Mounting experimental and clinical evidence strongly supports the notion that spermspecific PLC is the sole physiological stimulus of egg activation during mammalian fertilization [4, 8, [11] [12] [13] [14] [33] [34] [35] [36] . Sperm-delivered PLC triggers the repetitive Ca 2+ oscillations within the fertilized egg, by catalysing the hydrolysis of PIP2 stimulating the InsP3 signalling pathway [3, 9] . Although PLC is the smallest PLC isoform with the most basic domain structure organization, its discrete biochemical properties contribute to its supreme effectiveness in triggering the Ca 2+ signalling phenomenon within the fertilized mammalian eggs [9] .
The past few years, clinical reports have directly linked defects in human PLC with documented cases of male infertility. Firstly, Yoon et al., [11] reported a number of infertile patients presenting oocyte activation failure, providing evidence that was due to absence of reduced levels of PLC within their sperm [11] . Then, the first direct link between male infertility and a mutation on PLC gene came from a study that reported a mutation on the catalytic domain of PLC (H398P) of a patient who failed fertilization after ICSI [12] .
Interestingly, another study reported a second PLC mutation on the same heterozygous infertile patient, also in the catalytic domain (H233L) [14] . Recently, Escoffier et al., [8] reported a homozygous missense mutation in the PLC gene of two infertile brothers from Tunisia, presenting egg activation failure [8] . This mutation was located in the C2 domain of PLC where an Ile had been replaced with a Phe residue (I489F), (Fig. 1A) making it the first PLC mutation located in a different domain than the catalytic.
Here, we introduced the infertility-linked I489F PLC mutation in human PLC sequence and we assessed the effects of this mutation upon the in vivo Ca 2+ oscillation-inducing activity and the in vitro biochemical and enzymatic properties of human PLC. Our study provides evidence and extends the previous work of Escoffier et al., [8] by revealing that (i) PLCζ I489F mutation dramatically reduces the Ca 2+ oscillation-inducing activity of PLC in mouse and bovine eggs (Figs 1B, 2B, 4) . Although microinjection of physiological levels of PLC mutant are either unable or triggered very low frequency Ca 2+ oscillations in mouse and bovine eggs, a 2-fold increase in the amount of PLC microinjected in mouse eggs was capable of rescuing the defective Ca 2+ oscillation-inducing phenotype, triggering egg activation of these PLC I489F microinjected eggs (Fig. 3 ). This suggests that by overloading the egg with significantly higher amounts of this PLC mutant can lead to successful oocyte activation, explaining the infertility of the two heterozygous brothers carrying this mutation. (ii) CD spectroscopy showed that the I489F C2 mutation has no effect on the proper folding and the thermal stability of this domain (Fig. 6 ). This was consistent with our observations regarding the enzymatic properties of PLC I489F mutant, which were almost identical with the enzymatic properties of PLC WT (Fig. 7 , Table 2 ), suggesting that I489F mutation has no effect on the ability of PLC to hydrolyse PIP2. (iii) More importantly, our liposome binding experiments revealed that I489F mutation dramatically reduces (~50%) the binding of PLC to PI(3)P and PI(5)P (Figs. 8, 9 ), two phosphoinositides, which have been previously reported to interact with PLC in vitro [31, 32] . To the best of our knowledge, PLC C2 domain is the first C2 domain amongst the C2 domains of all PLC isoforms that it has been shown to directly interact with PI(3)P and PI(5)P, in vitro. Although it is difficult to predict which amino acid residues play a role on these interactions, we have shown that I489 is a key residue for efficient binding of PLC to both PI(3)P and PI(5)P. High resolution three-dimensional structure analysis of PLC C2 domain by X-ray crystallography could help to reveal the critical binding sites for these interactions. It is now also necessary to understand the physiological role of the binding of PLC to PI(3)P and PI(5)P and also to extensively search for any other unidentified membrane egg proteins, which might interact with the C2 domain of PLC, assisting with the proper localization and targeting of this enzyme within the egg cytoplasm.
It has been proposed, at least for mouse PLC, that its nuclear translocation ability regulates the cell-cycle dependent Ca 2+ oscillations [3] . It is worth noting that there is no scientific evidence for the C2 domain playing a role in the nuclear sequestration of PLC, as it has been clearly demonstrated that the nuclear localization signal (NLS) of mouse PLC is located within the XY linker region, close to the start of the Y domain [3] .
Understanding the complex mechanism of action of PLC requires further investigation. However, based on our previous and recent findings we propose that after spermegg fusion and the delivery of PLC from the sperm into the egg cytoplasm, the high Ca 2+
sensitivity of this prototypic PLC is conferred by its EF hand domains, allowing it to be active at resting egg Ca 2+ levels [27, 31, 37] . PLC may then associate with a specific intracellular membrane by interaction of the C2 domain with either PI(3)P, PI ( 
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TABLE LEGENDS
Table 2
In vitro enzymatic properties of MBP-tagged PLC WT and PLC I489F mutant Summary of specific enzyme activity, Km and EC50 values of Ca 2+ -dependence for PIP2 hydrolysis, determined by non-linear regression analysis (GraphPad Prism 5), (see Fig. 7 ). Table 2 ).
FIGURE LEGENDS
Figure 8 I489F mutation reduces the binding of PLC to PI(3)P and PI(5)P containing liposomes
Liposome 'pull-down assays' of MBP-tagged PLC WT and PLC I489F proteins. Unilamellar liposomes containing either PIP2 (1%), PI(3)P (5%), or PI(5)P (5%) were incubated with PLC recombinant proteins. Following liposome centrifugation, both the supernatant (s) and liposome pellet (p) were subjected to SDS-PAGE and Coomassie Brilliant Blue staining.
Figure 9
Quantitative analysis suggest that I489F mutation reduces ~50% the binding of PLC to
PI(3)P and PI(5)P containing liposomes
Normalized binding of MBP-PLC WT and MBP-PLC I489F recombinant proteins to unilamellar liposomes containing (A) 1% PIP2, (B) 5% PI(3)P and (C) 5% PI(5)P. Following centrifugation, the supernatants were assayed for their ability to hydrolyse PIP2 in vitro, using the standard [ 3 H]PIP2 hydrolysis assay, (n=4±SEM, using two different preparations of recombinant protein). Based on the % of the PIP2 hydrolytic activity pre-and post-liposome binding the relative binding of each PLC protein to the liposomes was determined. Significant statistical differences (asterisks) were calculated by an unpaired Student's t-test; ***P < 0.0005, (GraphPad, Prism 5).
Figure 10
Schematic illustration of a proposed intracellular targeting mechanism of PLC Our study suggests that association of PLC with a specific vesicular membrane may be mediated by interaction of the C2 domain with PI(3)P, PI (5) The high Ca 2+ sensitivity of the enzyme is conferred by the EF hand domain enabling PLC to be active at resting nanomolar Ca 2+ levels (Figure modified from [10] ). 
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